“Secondly, the majority of the CTO patients in this ISCHEMIA substudy have two- or three-vessel disease. This means that they have had other lesions revascularized as well. So, the prognostic benefit ...

Pini-CTO in Milan, Italy, and colleagues. Risk of recurrence was also reduced significantly when tapering was started only when patients had shown inactive disease for at least 2 years (HR 0.65, 95% ...